State of Alaska Department of Revenue Buys 12,273 Shares of Colgate-Palmolive (NYSE:CL)

State of Alaska Department of Revenue boosted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 11.1% in the 4th quarter, Holdings Channel reports. The institutional investor owned 123,157 shares of the company’s stock after buying an additional 12,273 shares during the quarter. State of Alaska Department of Revenue’s holdings in Colgate-Palmolive were worth $11,195,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CL. Chicago Partners Investment Group LLC grew its holdings in Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $1,315,000. Gordian Advisors LLC bought a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $602,000. Carrera Capital Advisors grew its position in Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after acquiring an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth $4,066,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 1.2 %

Colgate-Palmolive stock opened at $85.60 on Friday. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The stock has a 50-day moving average price of $90.78 and a 200 day moving average price of $96.92. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $69.94 billion, a price-to-earnings ratio of 24.32, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company posted $0.87 EPS. Sell-side analysts anticipate that Colgate-Palmolive will post 3.74 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.34%. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CL. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday. Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday. Raymond James reiterated an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday. TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $101.16.

View Our Latest Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.